Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion.

Satpathy AT, Granja JM, Yost KE, Qi Y, Meschi F, McDermott GP, Olsen BN, Mumbach MR, Pierce SE, Corces MR, Shah P, Bell JC, Jhutty D, Nemec CM, Wang J, Wang L, Yin Y, Giresi PG, Chang ALS, Zheng GXY, Greenleaf WJ, Chang HY.

Nat Biotechnol. 2019 Aug;37(8):925-936. doi: 10.1038/s41587-019-0206-z. Epub 2019 Aug 2.

PMID:
31375813
2.

Clonal replacement of tumor-specific T cells following PD-1 blockade.

Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, Gupta RK, Curtis C, Bucktrout SL, Davis MM, Chang ALS, Chang HY.

Nat Med. 2019 Aug;25(8):1251-1259. doi: 10.1038/s41591-019-0522-3. Epub 2019 Jul 29.

PMID:
31359002
3.

Rapid and reversible suppression of ALT by DAXX in osteosarcoma cells.

Yost KE, Clatterbuck Soper SF, Walker RL, Pineda MA, Zhu YJ, Ester CD, Showman S, Roschke AV, Waterfall JJ, Meltzer PS.

Sci Rep. 2019 Mar 14;9(1):4544. doi: 10.1038/s41598-019-41058-8.

4.

Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.

Chang ALS, Tran DC, Cannon JGD, Li S, Jeng M, Patel R, Van der Bokke L, Pague A, Brotherton R, Rieger KE, Satpathy AT, Yost KE, Reddy S, Sarin K, Colevas AD.

J Am Acad Dermatol. 2019 Feb;80(2):564-566. doi: 10.1016/j.jaad.2018.08.017. Epub 2018 Aug 24. No abstract available.

5.

Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.

Cho SW, Xu J, Sun R, Mumbach MR, Carter AC, Chen YG, Yost KE, Kim J, He J, Nevins SA, Chin SF, Caldas C, Liu SJ, Horlbeck MA, Lim DA, Weissman JS, Curtis C, Chang HY.

Cell. 2018 May 31;173(6):1398-1412.e22. doi: 10.1016/j.cell.2018.03.068. Epub 2018 May 3.

6.

ATAC Primer Tool for targeted analysis of accessible chromatin.

Yost KE, Carter AC, Xu J, Litzenburger U, Chang HY.

Nat Methods. 2018 Apr 27;15(5):304-305. doi: 10.1038/nmeth.4663. No abstract available.

Supplemental Content

Support Center